Effects of Pristane Alone or Combined with Chloroquine on Macrophage Activation, Oxidative Stress, and Th1/Th2 Skewness

Table 2

Hematological parameters.

	12 wks after treatment			24 wks after treatment
	Control	Pristane	Chloroquine	Control	Pristane
RBCs (10^12/L)	10.40±1.51	7.62±0.84^∗	9.37±1.44^#	10.15±1.73	8.25±1.21^∗
HGB (g/L)	151.17±10.61	91.41±14.81^∗	135.74±17.25^#	145.3±15.4	113.01±11.34^∗
Reticulocytes (10^9)	342±81	326±97	307±75	319±64	378±101^∗
WBCs (10^9/L)	10.11±3.15	7.15±2.16^∗	8.64±1.65^∗	9.84±2.80	8.63±1.51^∗
Platelet (10^9/L)	493±125	745±146^∗	615±94^∗	508±98	821±163^∗

RBCs: red blood cells; HGB: hemoglobin; WBCs: white blood cells. ^∗𝑃<0.05 versus corresponding control mice, ^#𝑃<0.05 versus mice exposed to pristane for 12 weeks. Results are expressed as mean ± SE for seven animals.